Psychedelic-Assisted Therapy with Andrew Penn

Published: Feb. 22, 2022, 11 a.m.

b'

Andrew Penn, MS, NP, PMHNP-BC is a University of California San Francisco trained psychiatric nurse practitioner, nationally-recognized speaker on psychedelic assisted therapy and cannabinoids in psychiatry and a co-founder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses). Andrew completed extensive training in psychedelic assisted therapy and has worked as a study therapist on a phase 3 MDMA-assisted therapy protocol for PTSD and is Co-investigator on a study of psilocybin assisted therapy for major depression. He speaks to us today about psychedelic-assisted therapies.

Episode Highlights:
- What Post-Traumatic Stress Disorder (PTSD) is
- The parts of the brain affected by traumatic experiences
- "Window of Tolerance" after trauma
- The history of MDMA and psychedelics
- MDMA-assisted therapy for PTSD
- How psychedelics can be seen as a "quick fix"
- Why psychedelic medicine is considered contextual
- Psilocybin assisted therapy for major depression
- The default-mode network vs the task-positive network
- Barriers in this field of psychedelic research


For more information about Andrew Penn, please visit
https://www.andrewpennnp.com/

Organization of Psychedelic and Entheogenic Nurses
https://www.openurses.org/

Laboratory
https://psychedelics.ucsf.edu/

Contact Us
info@blumatterproject.com
https://blumatterproject.com/\\xa0

'